Map Grants, Tax Relief, and Eligibility Sequences
The founder explicitly maps out the chronological stack of non-dilutive options, covering Innovate UK grants, R&D tax credits, and local enterprise growth funds. They model the precise timing requirements, dependency chains, match-funding obligations, and subsidy control limits across all mechanisms. This reveals how cash flows from public funds interact over time.
Completing this action establishes a realistic timeline for cash inflows and critical eligibility dependencies across all non-dilutive sources. This ensures the venture avoids double-counting project costs or breaching state subsidy limits that could invalidate future claims.
A detailed non-dilutive funding matrix displaying application dates, expected award cashflows, required match-funding percentages, and subsidy control declarations. The output must clearly articulate how early grant choices impact subsequent R&D tax relief or equity funding rounds.
Five questions an expert would ask when reviewing your output
Use these to challenge assumptions, pressure-test your logic, and check the quality of this action's output in the context of the parent task and wider venture development.
- 1
What specific subsidy control rules or state aid caps apply to this combined sequence of public funding awards?
- 2
How will your operational cash flow absorb the typical three to six-month delay between winning a grant award and receiving the first draw-down?
- 3
Why have you assumed that grant match-funding can be sourced entirely from non-dilutive channels rather than requiring upfront equity?
- 4
Where does the boundary sit between work funded by non-dilutive grants and activities that qualify under current UK R&D tax relief definitions?
- 5
What risk does your proposed grant sequencing create for the timing of your next equity investment round?